Embecta Corp. (EMBC) vs Enanta Pharmaceuticals, Inc. (ENTA)
A side-by-side comparison of Embecta Corp. and Enanta Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EMBC
Embecta Corp.
$5.95HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ENTA
Enanta Pharmaceuticals, Inc.
$12.17HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — EMBC vs ENTA
growth of $100 · dividends reinvested · last 5yEMBC -85.5% (-32.1%/yr)ENTA -81.7% (-28.8%/yr)ENTA compounded faster over this window
EMBC ENTA
EMBC vs ENTA: by the numbers
- •ENTA is the larger company ($354M vs $353M market cap).
- •EMBC is profitable (8.59% net margin) while ENTA runs a net loss (-96.89%).
- •Both shrank revenue over the past five years; EMBC's decline was smaller (-0.09% vs -7.65% CAGR).
- •EMBC pays a dividend (5.44% yield), while ENTA has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | EMBC | ENTA |
|---|---|---|
| P/E ratio | 4.02 | N/A |
| Forward P/E | 3.38 | N/A |
| P/S ratio | 0.35 | 5.42 |
| P/B ratio | N/A | 3.50 |
| EV / EBITDA | 5.38 | N/A |
| FCF yield | 46.63% | N/A |
Profitability
| Metric | EMBC | ENTA |
|---|---|---|
| Gross margin | 59.89% | 98.15% |
| Operating margin | 24.85% | -130.65% |
| Net margin | 8.59% | -96.89% |
| ROE | N/A | -62.56% |
| ROIC | 17.99% | -24.20% |
Dividends
| Metric | EMBC | ENTA |
|---|---|---|
| Dividend yield | 5.44% | N/A |
| Payout ratio | 21.62% | N/A |
Growth (annualized)
| Metric | EMBC | ENTA |
|---|---|---|
| Revenue CAGR (5Y) | -0.09% | -7.65% |
| EPS CAGR (5Y) | -26.22% | N/A |
| FCF CAGR (5Y) | -16.77% | N/A |
| Total return CAGR (5Y) | N/A | -26.94% |
Frequently asked
- Which has grown faster, EMBC or ENTA?
- Neither grew: over the past five years both shrank revenue, with EMBC's decline the smaller — EMBC at a -0.09% CAGR versus ENTA at -7.65%.
- Does EMBC or ENTA pay a bigger dividend?
- EMBC pays a dividend (5.44% yield), while ENTA has no payments in the available dividend history.
- Is EMBC or ENTA more profitable?
- EMBC runs the higher net margin — EMBC at 8.59% versus ENTA at -96.89%.
Go deeper
Dig into the metrics
Embecta P/E ratioEmbecta dividend yieldEmbecta ROEEnanta Pharmaceuticals ROEEmbecta operating marginEnanta Pharmaceuticals operating marginEmbecta revenue growthEnanta Pharmaceuticals revenue growthEmbecta free cash flowEnanta Pharmaceuticals free cash flow
Embecta & Enanta Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.